Global Financial Private Client’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,917
Closed -$236K 232
2025
Q3
$236K Buy
+1,917
New +$238K 0.08% 210
2025
Q2
Sell
-269
Closed -$39.6K 479
2025
Q1
$39.6K Buy
269
+14
+5% +$2.14K 0.02% 358
2024
Q4
$41.4K Buy
255
+5
+2% +$818 0.02% 338
2024
Q3
$40.7K Hold
250
0.02% 338
2024
Q2
$34.1K Hold
250
0.01% 337
2024
Q1
$37.9K Hold
250
0.02% 330
2023
Q4
$35.6K Hold
250
0.02% 327
2023
Q3
$32.6K Hold
250
0.02% 324
2023
Q2
$40.1K Hold
250
0.02% 308
2023
Q1
$39.2K Hold
250
0.02% 302
2022
Q4
$35.1K Hold
250
0.02% 307
2022
Q3
$32.4K Hold
250
0.02% 307
2022
Q2
$36K Hold
250
0.02% 292
2022
Q1
$35.7K Hold
250
0.02% 301
2021
Q4
$43.6K Hold
250
0.02% 279
2021
Q3
$41.1K Hold
250
0.02% 261
2021
Q2
$44.7K Hold
250
0.03% 258
2021
Q1
$48.2K Hold
250
0.03% 209
2020
Q4
$50.5K Hold
250
0.04% 194
2020
Q3
$52.9K Hold
250
0.05% 180
2020
Q2
$54.9K Hold
250
0.05% 195
2020
Q1
$43.7K Hold
250
0.05% 222
2019
Q4
$38.4K Buy
+250
New +$37.4K 0.03% 269

Other funds holding CLX

Global Financial Private Client's CLX Position: Q4 2025 in Review

Global Financial Private Client sold out of Clorox (CLX) in Q4 2025, closing a stake of 1,917 shares — an estimated $236K sold.

Global Financial Private Client first reported a position in CLX in Q4 2019 and held it in 23 quarters. The position peaked at $236K in Q3 2025. 1,050 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Global Financial Private Client reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Global Financial Private Client sold 1,917 Clorox shares in Q4 2025, an estimated $236K.
  • Global Financial Private Client first reported a position in Clorox in Q4 2019 and held it in 23 quarters.
  • Global Financial Private Client's Clorox position peaked at $236K in Q3 2025.
  • 1,050 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Global Financial Private Client's 13F filing for Q4 2025, filed 27 Jan 2026.